Relating to financial assistance available for a prescription drug
HB 5483 requires health insurers and pharmacy benefits managers (PBMs) to include all cost-sharing payments (like copays or deductibles) made by patients or others when calculating a patient's total out-of-pocket costs for prescription drugs. It applies annual cost-sharing limits to all health plans sold in West Virginia and prohibits insurers or PBMs from altering coverage terms based on whether a patient has financial assistance for a drug. The bill directly affects patients using prescription drugs, insurers, PBMs, and third-party administrators, ensuring their coverage terms remain unchanged regardless of available drug financial help. Violations carry civil penalties up to $10,000 per incident, with restitution required for affected patients. The law takes effect for new plans on or after January 1, 2027.
Bill status
in committee
1 of 4 stages cleared
Introduction
Feb 2026
Committee Review
Floor Vote
Governor
Introduced Feb 12, 2026
Last action Feb 16, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
5
Key actions
0
Committee
3
Feb 16, 2026
Committee
To House Banking and Insurance
lower
Feb 12, 2026
Committee
To House Finance
lower
Feb 12, 2026
Introduced
Introduced in House
lower
Feb 12, 2026
Committee
To Finance
lower
1 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Matthew Rohrbach
RRepublican
Ask Maddy
·
AI policy assistant
Ask Maddy about HB 5483
Scope: WV
Hi! I can help you understand HB 5483. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline